The changes in the content of specific VGF peptides after PCP treatment found in this study, may suggest a role for these peptides acting as neuromodulators on the release of neurotransmitters crucial for neuropathology of schizophrenia, which may have a potential importance for therapeutic approaches. The gene discussed is VGF; the disease is schizophrenia.